References

1. Beutler, E.; Grabowski, G.A. Gaucher Disease. In The Metabolic and Molecular Bases of Inherited Diseases; Beutler, E., Grabowski, G.A., Eds.; McGraw-Hill: New York, 2001; Vol. III, 3635-3668.

2. Grabowski, G.A.; Horowitz, M. Gaucher's disease: Molecular, genetic and enzymological aspects. Bailliere's Clin. Haematol. 1997, 10, 635-656.

3. Brady, R.O.; Barton, N.W.; Grabowski, G.A. The role of neurogenetics in Gaucher disease. Arch. Neurol. 1993, 50, 1212-1224.

4. Abrahamov, A.; Elstein, D.; Gross-Tsur, V.; Farber, B.; Glaser, Y.; Hadas-Halpern, I.; Ronen, S.; Tafakjdi, M.; Horowitz, M.; Zimran, A. Gaucher's disease variant characterized by progressive calcification of heart valves and unique genotype. Lancet 1995, 346, 1000-1003.

5. Elstein, Y.; Eisenberg, V.; Granovsky-Grisaru, S.; 16. Rabinowitz, R.; Samueloff, A.; Zimran, A.; Elstein, D. Outcome of pregnancies in Gaucher disease: A five-year prospective study among women treated with enzyme and untreated and a survey of the literature. Am. J. Obstet. Gynecol. 2004, 190, 435-441. 17.

6. Neudorfer, O.; Giladi, N.; Elstein, D.; Abrahamov, A.; Turezkie, T.; Aghai, E.; Reches, A.; Bembi, B.; Zimran, A. Occurrence of Parkinson's syndrome in type I Gaucher disease. Q. J. Med. 1996, 89, 691-694.

Stone, D.L.; Carey, W.F.; Christodoulou, J.; Sillence, D.; Nelson, P.; Callahan, M.; Tayebi, N.; Sidransky, E. Type 2 Gaucher disease: The collodion baby phenotype revisited. Arch. Dis. Child., Fetal Neonatal Ed. 2000, 82, F163-166.

Hollak, C.E.M.; van Weely, S.; van Oers, M.H.J.; Aerts, J.M.F.G. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J. Clin. Invest. 1994, 98, 1288-1292.

Ringden, O.; Groth, C.G.; Erikson, A.; Granqvist, S.; Mansson, J.E.; Sparrelid, E. Ten years' experience of bone marrow transplantation for Gaucher disease. Transplantation 1995, 59, 864-870.

Barton, N.W.; Brady, R.O.; Dambrosia, J.M.; Di Bisceglie, A.M.; Doppelt, S.H.; Hill, S.C.; Mankin, H.J.; Murray, G.J.; Parker, R.I.; Argoff, C.E.; et al. Replacement therapy for inherited enzyme deficiency—Macrophage-targeted glucocerebrosidase for Gaucher's disease. N. Engl. J. Med. 1991, 324, 1464-1470.

Weinreb, N.J.; Charrow, J.; Andersson, H.C.; Kaplan, P.; Kolodny, E.H.; Mistry, P.; Pastores, G.; Rosenbloom, B.E.; Scott, C.R.; Wappner, R.S.; Zimran, A. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: A report from the Gaucher Registry. Am. J. Med. 2002, 113, 112119.

Dweck, A.; Abrahamov, A.; Hadas-Halpern, I.; Bdolach-Avram, T.; Zimran, A.; Elstein, D. Type I Gaucher disease in children with and without enzyme therapy. Pediatr. Hematol. Oncol. 2002, 19, 389-397. Elstein, D.; Klutstein, M.W.; Lahad, A.; Abrahamov, A.; Hadas-Halpern, I.; Zimran, A. Echocardiographic assessment of pulmonary hypertension in Gaucher disease. Lancet 1998, 351, 1544-1546.

Elstein, D.; Abrahamov, A.; Hadas-Halpern, I.; Zimran, A. Withdrawal of enzyme replacement therapy in Gaucher disease. Br. J. Haematol. 2000, 110, 488-492. Cox, T.; Lachmann, R.; Hollak, C.; Aerts, J.; van Weely, S.; Hrebicek, M.; Platt, F.; Butters, T.; Dwek, R.; Moyses, C.; Gow, I.; Elstein, D.; Zimran, A. Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet 2000, 355, 1481-1485.

Sawkar, A.R.; Cheng, W.C.; Beutler, E.; Wong, C.H.; Balch, W.E.; Kelly, J.W. Chemical chaperones increase the cellular activity of N370S beta-glucosidase: A therapeutic strategy for Gaucher disease. Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 15428-15433. Choudary, P.V.; Tsuji, S.; Martin, B.M.; Guild, B.C.; Mulligan, R.C.; Murray, G.J.; Barranger, J.A.; Ginns, E.I. The molecular biology of Gaucher disease and the potential for gene therapy. Cold Spring Harbor Symp. Quant. Biol. 1986, 51 (Part 2), 1047-1052.

Getting Started With Dumbbells

Getting Started With Dumbbells

The use of dumbbells gives you a much more comprehensive strengthening effect because the workout engages your stabilizer muscles, in addition to the muscle you may be pin-pointing. Without all of the belts and artificial stabilizers of a machine, you also engage your core muscles, which are your body's natural stabilizers.

Get My Free Ebook


Post a comment